CellaVision Past Earnings Performance
Past criteria checks 5/6
CellaVision has been growing earnings at an average annual rate of 8.4%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 10.2% per year. CellaVision's return on equity is 19.6%, and it has net margins of 20.4%.
Key information
8.4%
Earnings growth rate
6.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.2% |
| Return on equity | 19.6% |
| Net Margin | 20.4% |
| Next Earnings Update | 06 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How CellaVision makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 737 | 150 | 219 | 86 |
| 30 Jun 24 | 726 | 145 | 217 | 83 |
| 31 Mar 24 | 708 | 141 | 213 | 84 |
| 31 Dec 23 | 677 | 130 | 213 | 83 |
| 30 Sep 23 | 629 | 112 | 202 | 83 |
| 30 Jun 23 | 602 | 97 | 196 | 91 |
| 31 Mar 23 | 616 | 99 | 196 | 91 |
| 31 Dec 22 | 639 | 118 | 191 | 89 |
| 30 Sep 22 | 651 | 126 | 194 | 86 |
| 30 Jun 22 | 642 | 142 | 186 | 72 |
| 31 Mar 22 | 594 | 135 | 174 | 67 |
| 31 Dec 21 | 566 | 125 | 165 | 64 |
| 30 Sep 21 | 532 | 114 | 160 | 61 |
| 30 Jun 21 | 488 | 101 | 150 | 54 |
| 31 Mar 21 | 471 | 98 | 147 | 52 |
| 31 Dec 20 | 471 | 89 | 152 | 51 |
| 30 Sep 20 | 490 | 85 | 159 | 54 |
| 30 Jun 20 | 498 | 89 | 165 | 59 |
| 31 Mar 20 | 492 | 92 | 163 | 60 |
| 31 Dec 19 | 462 | 99 | 150 | 56 |
| 30 Sep 19 | 423 | 104 | 135 | 53 |
| 30 Jun 19 | 412 | 104 | 131 | 48 |
| 31 Mar 19 | 391 | 97 | 124 | 43 |
| 31 Dec 18 | 365 | 89 | 120 | 39 |
| 30 Sep 18 | 330 | 76 | 114 | 33 |
| 30 Jun 18 | 307 | 67 | 109 | 30 |
| 31 Mar 18 | 294 | 63 | 106 | 27 |
| 31 Dec 17 | 309 | 70 | 106 | 27 |
| 30 Sep 17 | 306 | 70 | 101 | 28 |
| 30 Jun 17 | 313 | 78 | 97 | 28 |
| 31 Mar 17 | 300 | 75 | 92 | 30 |
| 31 Dec 16 | 265 | 60 | 86 | 29 |
| 30 Sep 16 | 254 | 57 | 85 | 29 |
| 30 Jun 16 | 260 | 66 | 82 | 27 |
| 31 Mar 16 | 246 | 55 | 82 | 28 |
| 31 Dec 15 | 239 | 53 | 82 | 27 |
| 30 Sep 15 | 250 | 49 | 84 | 29 |
| 30 Jun 15 | 223 | 30 | 82 | 28 |
| 31 Mar 15 | 226 | 34 | 83 | 25 |
| 31 Dec 14 | 217 | 31 | 80 | 23 |
| 30 Sep 14 | 209 | 33 | 73 | 19 |
| 30 Jun 14 | 207 | 36 | 70 | 17 |
| 31 Mar 14 | 189 | 26 | 67 | 18 |
| 31 Dec 13 | 180 | 19 | 66 | 21 |
Quality Earnings: CLVS.F has high quality earnings.
Growing Profit Margin: CLVS.F's current net profit margins (20.4%) are higher than last year (17.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLVS.F's earnings have grown by 8.4% per year over the past 5 years.
Accelerating Growth: CLVS.F's earnings growth over the past year (33.9%) exceeds its 5-year average (8.4% per year).
Earnings vs Industry: CLVS.F earnings growth over the past year (33.9%) exceeded the Medical Equipment industry 10.4%.
Return on Equity
High ROE: CLVS.F's Return on Equity (19.6%) is considered low.